Aggregation-defective α-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked α-synuclein variants

被引：19

作者：

Koo, Hyun-Jung ^{[1
]}

Choi, Min Yeong ^{[1
]}

Im, Hana ^{[1
]}

机构：

[1] Sejong Univ, Dept Mol Biol, Seoul 143747, South Korea

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2009年 / 386卷 / 01期

关键词：

Conformational switch; Protein amyloid; Protein fibrils; Protein folding; alpha-Synuclein; ALZHEIMERS-DISEASE; BETA-SHEET; MUTATION; FIBRILS; E46K; NEURODEGENERATION; FIBRILLOGENESIS; FIBRILLIZATION; PATHOGENESIS; DUPLICATION;

D O I：

10.1016/j.bbrc.2009.06.002

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

alpha-Synuclein comprises the fibrillar core of Lewy bodies, which is one of the histologically defining lesions of Parkinson's disease. Previously, we screened for alpha-synuclein substitution mutants that do not form fibrils. For preventative or therapeutic uses, it is essential to suppress the oligomerization/fibrillation of the wild-type and PD-linked alpha-synuclein proteins. Here we have examined the effects of fibrillation-retarded alpha-synuclein mutants on fibril formation by wild-type and PD-linked alpha-synuclein molecules. Six self-aggregation-defective alpha-synuclein mutants completely inhibit the fibrillation of both wild-type and Parkinson's disease-linked of alpha-synuclein variants. These results suggest future applications for gene therapy: the transplantation of a fibrillation-blocking mutant alpha-synuclein gene into individuals who carry an early-onset PD-associated alpha-synuclein allele. Short synthetic peptides derived from these mutant sequences may also serve as a lead compound for the development of therapeutics for Parkinson's disease. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：165 / 169

页数：5

共 29 条

[1] Toxicity of non-Aβ component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of β-sheet structure and fibrils [J].

Bodles, AM ;

Guthrie, DJS ;

Harriott, P ;

Campbell, P ;

Irvine, GB .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (08) :2186-2194

[2] α-synuclein locus duplication as a cause of familial Parkinson's disease [J].

Chartier-Harlin, MC ;

Kachergus, J ;

Roumier, C ;

Mouroux, V ;

Douay, X ;

Lincoln, S ;

Levecque, C ;

Larvor, L ;

Andrieux, J ;

Hulihan, M ;

Waucquier, N ;

Defebvre, L ;

Amouyel, P ;

Farrer, M ;

Destée, A .

LANCET, 2004, 364 (9440) :1167-1169

[3] Mutation E46K increases phospholipid binding and assembly into filaments of human α-synuclein [J].

Choi, W ;

Zibaee, S ;

Jakes, R ;

Serpell, LC ;

Davletov, B ;

Crowther, RA ;

Goedert, M .

FEBS LETTERS, 2004, 576 (03) :363-368

[4] Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].

Conway, KA ;

Lee, SJ ;

Rochet, JC ;

Ding, TT ;

Williamson, RE ;

Lansbury, PT .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576

[5] Molecular pathways of neurodegeneration in Parkinson's disease [J].

Dawson, TM ;

Dawson, VL .

SCIENCE, 2003, 302 (5646) :819-822

[6] Structural organization of α-synuclein fibrils studied by site-directed spin labeling [J].

Der-Sarkissian, A ;

Jao, CC ;

Chen, J ;

Langen, R .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37530-37535

[7] A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human α-synuclein [J].

Du, HN ;

Tang, L ;

Luo, XY ;

Li, HT ;

Hu, J ;

Zhou, JW ;

Hu, HY .

BIOCHEMISTRY, 2003, 42 (29) :8870-8878

[8] A Drosophila model of Parkinson's disease [J].

Feany, MB ;

Bender, WW .

NATURE, 2000, 404 (6776) :394-398

[9] A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly [J].

Giasson, BI ;

Murray, IVJ ;

Trojanowski, JQ ;

Lee, VMY .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (04) :2380-2386

[10]

GOETZ CG, 2002, PARKINSONS DIS DIAGN, P19

← 1 2 3 →